Newsroom

Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.

07/31/2019, Wednesday

Bausch + Lomb Initiates First Clinical For Technolas® Teneo™ Excimer Laser in The United States

07/24/2019, Wednesday

Bausch + Lomb Showcases New Retina Innovations at In-Booth Wet Lab During The Annual Meeting of The American Society of Retina Specialists

07/23/2019, Tuesday

Bausch + Lomb Introduces FreeFlow™ Infusion System For Retina Surgery

07/22/2019, Monday

Bausch + Lomb Introduces 23-Gauge Bi-Blade® Dual Port Vitrectomy Cutter For The Stellaris Elite™ Vision Enhancement System

07/09/2019, Tuesday

Bausch + Lomb Launches Ocuvite® Eye Performance Vitamins

6/19/2019, Wednesday

Bausch + Lomb ULTRA® Multifocal For Astigmatism Contact Lenses Now Available For The First Time As A Standard Offering in Fit Sets

4/29/2019, Monday

Bausch + Lomb Announces Update From Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study

4/29/2019, Monday

Bausch + Lomb Invites Surgeons to New In-Booth Experience Exchange™, Events and Scientific Presentations During the Annual Meeting of the American Society of Cataract and Refractive Surgery

4/26/2019, Friday

New Scientific and Clinical Analyses Regarding Bausch + Lomb Surgical and Pharmaceutical Products to be Presented During the Association in Vision and Ophthalmology Meeting

4/23/2019, Tuesday

Bausch + Lomb Announces New Divisional Leadership In The U.S.

4/22/2019, Monday

Bausch + Lomb to Initiate Series of U.S. Clinical Trials for Technolas® Teneo™ Excimer Laser

4/22/2019, Monday

Bausch + Lomb Reports More Than 9.2 Million Units of Contact Lens Materials Diverted From Waste Stream Through ONE by ONE Recycling Program

4/2/2019, Tuesday

Bausch + Lomb Announces The U.S. Launch Of LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% For The Treatment Of Post-Operative Inflammation And Pain Following Ocular Surgery

2/25/2019, Monday

Bausch + Lomb Announces FDA Approval of LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38% For The Treatment of Postoperative Inflammation And Pain Following Ocular Surgery

2/13/2019, Wednesday

Bausch + Lomb Receives 510(K) Clearance For Use Of The Tangible® Hydra-PEG® Custom Contact Lens Coating Technology On Several Of Its Boston® Gas Permeable Materials And Zenlens™ Family Of Scleral Lenses

2/4/2019, Monday

Bausch + Lomb Launches SIGHTMATTERS.COM to Help People Living with Age-Related Macular Degeneration Take Control of Their Condition

1/22/2019, Tuesday

Bausch + Lomb Introduces ZEN™ Multifocal Scleral Lens for Presbyopia

12/5/2018, Wednesday

Bausch + Lomb Receives 510(K) Clearance From FDA FOR Bausch + Lomb ULTRA® Multifocal for Astigmatism Contact Lenses

12/4/2018, Tuesday

Bausch + Lomb Announces Exclusive Agreement with Modulight to Develop New Photodynamic Laser

11/15/2018, Thursday

Bausch + Lomb Reports More Than Five Million Units of Contact Lens Materials Recycled by Second Anniversary of ONE by ONE Recycling Program

1234567Last